Publication:
Analysis of viral diversity for vaccine target discovery

dc.contributor.authorAsif M. Khanen_US
dc.contributor.authorYongli Huen_US
dc.contributor.authorOlivo Miottoen_US
dc.contributor.authorNatascha M. Thevasagayamen_US
dc.contributor.authorRashmi Sukumaranen_US
dc.contributor.authorHadia Syahirah Abd Ramanen_US
dc.contributor.authorVladimir Brusicen_US
dc.contributor.authorTin Wee Tanen_US
dc.contributor.authorJ. Thomas Augusten_US
dc.contributor.otherPerdana Universityen_US
dc.contributor.otherJohns Hopkins Universityen_US
dc.contributor.otherYong Loo Lin School of Medicineen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherGriffith Universityen_US
dc.date.accessioned2018-12-21T06:36:47Z
dc.date.accessioned2019-03-14T08:02:36Z
dc.date.available2018-12-21T06:36:47Z
dc.date.available2019-03-14T08:02:36Z
dc.date.issued2017-12-21en_US
dc.description.abstract© 2017 The Author(s). Background: Viral vaccine target discovery requires understanding the diversity of both the virus and the human immune system. The readily available and rapidly growing pool of viral sequence data in the public domain enable the identification and characterization of immune targets relevant to adaptive immunity. A systematic bioinformatics approach is necessary to facilitate the analysis of such large datasets for selection of potential candidate vaccine targets. Results: This work describes a computational methodology to achieve this analysis, with data of dengue, West Nile, hepatitis A, HIV-1, and influenza A viruses as examples. Our methodology has been implemented as an analytical pipeline that brings significant advancement to the field of reverse vaccinology, enabling systematic screening of known sequence data in nature for identification of vaccine targets. This includes key steps (i) comprehensive and extensive collection of sequence data of viral proteomes (the virome), (ii) data cleaning, (iii) large-scale sequence alignments, (iv) peptide entropy analysis, (v) intra- and inter-species variation analysis of conserved sequences, including human homology analysis, and (vi) functional and immunological relevance analysis. Conclusion: These steps are combined into the pipeline ensuring that a more refined process, as compared to a simple evolutionary conservation analysis, will facilitate a better selection of vaccine targets and their prioritization for subsequent experimental validation.en_US
dc.identifier.citationBMC Medical Genomics. Vol.10, (2017)en_US
dc.identifier.doi10.1186/s12920-017-0301-2en_US
dc.identifier.issn17558794en_US
dc.identifier.other2-s2.0-85039052418en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/41639
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85039052418&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleAnalysis of viral diversity for vaccine target discoveryen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85039052418&origin=inwarden_US

Files

Collections